Clinical Trials Browser

Phase 2/3 × Advanced Gastric or Gastroesophageal Junction Adenocarcinoma × Clear all

NCT04435652 2020-06-17

A Study of QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer.

Phase 2/3 Unknown

Gastrointestinal

Advanced Gastric or Gastroesophageal Junction Adenocarcinoma